Showing results (41-50 of 71) with videos related to
Sort By:
Pageof 8
Frontiers in Oncology|March 21, 2022
Lenvatinib Beyond First-Line Therapy in Patients With Advanced Biliary Tract CarcinomaYunchao Wang, Xiaobo Yang, Dongxu Wang, et al.Frontiers in Immunology|February 6, 2023
Efficacy and safety of lenvatinib combined with PD-1/PD-L1 inhibitors plus Gemox chemotherapy in advanced biliary tract cancerChengpei Zhu, Jingnan Xue, Yunchao Wang, et al.Oncotarget|September 27, 2017
Identification of hub genes involved in the development of hepatocellular carcinoma by transcriptome sequencingYongchang Zheng, Junyu Long, Liangcai Wu, et al.Annals of Translational Medicine|August 15, 2020
Expression of p42.3 in non-small cell lung cancerXinmu Zhang, Xin Nie, Junyu Long, et al.Oncology Reports|September 24, 2019
Transcriptomic analysis and identification of prognostic biomarkers in cholangiocarcinomaHanyu Li, Junyu Long, Fucun Xie, et al.Cancers|July 20, 2021
Identification of a Novel Tumor Microenvironment Prognostic Signature for Advanced-Stage Serous Ovarian CancerMingjun Zheng, Junyu Long, Anca Chelariu-Raicu, et al.Cancer Immunology, Immunotherapy : CII|January 13, 2022
A real-world study of the efficacy and safety of anti-PD-1 antibodies plus lenvatinib in patients with advanced gallbladder cancerBangyou Zuo, Xiaobo Yang, Xu Yang, et al.Briefings in Bioinformatics|October 14, 2020
Transcriptional landscape of cholangiocarcinoma revealed by weighted gene coexpression network analysisJunyu Long, Shan Huang, Yi Bai, et al.Journal of Cancer|February 3, 2021
Apatinib as non-first-line treatment in patients with Intrahepatic CholangiocarcinomaJinzhu Mao, Xu Yang, Jianzhen Lin, et al.Aging|July 25, 2019
The diagnostic and prognostic role of RhoA in hepatocellular carcinomaYi Bai, Fucun Xie, Fei Miao, et al.Pageof 8